|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang L, Zheng RS, Wang N, Zeng HM, Yuan
YN, Zhang SW, Li HC, Liu S, Chen WQ and He J: Analysis of incidence
and mortality of thyroid cancer in China, 2013. Zhonghua Zhong Liu
Za Zhi. 39:862–867. 2017.In Chinese. PubMed/NCBI
|
|
3
|
Cronin KA, Lake AJ, Scott S, Sherman RL,
Noone AM, Howlader N, Henley SJ, Anderson RN, Firth AU, Ma J, et
al: Annual report to the nation on the status of cancer, part I:
National cancer statistics. Cancer. 124:2785–2800. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yassa L, Cibas ES, Benson CB, Frates MC,
Doubilet PM, Gawande AA, Moore FD Jr, Kim BW, Nose V, Marqusee E,
et al: Long-term assessment of a multidisciplinary approach to
thyroid nodule diagnostic evaluation. Cancer. 111:508–516. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cooper DS, Doherty GM, Haugen BR, Kloos
RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F,
Schlumberger M, et al: Revised American Thyroid Association
management guidelines for patients with thyroid nodules and
differentiated thyroid cancer. Thyroid. 19:1167–1214. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sahin M, Gursoy A, Tutuncu NB and Guvener
DN: Prevalence and prediction of malignancy in cytologically
indeterminate thyroid nodules. Clin Endocrinol (Oxf). 65:514–518.
2006. View Article : Google Scholar
|
|
7
|
Gomez Saez JM: Diagnostic and prognostic
markers in differentiated thyroid cancer. Curr Genomics.
12:597–608. 2011. View Article : Google Scholar
|
|
8
|
Jegerlehner S, Bulliard JL, Aujesky D,
Rodondi N, Germann S, Konzelmann I and Chiolero A: Overdiagnosis
and overtreatment of thyroid cancer: A population-based temporal
trend study. PLoS One. 12:e01793872017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miller KD, Nogueira L, Mariotto AB,
Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL and Siegel
RL: Cancer treatment and survivorship statistics, 2019. CA Cancer J
Clin. 69:363–385. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tkach M and Thery C: Communication by
extracellular vesicles: Where we are and where we need to go. Cell.
164:1226–1232. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Raposo G and Stoorvogel W: Extracellular
vesicles: Exosomes, microvesicles, and friends. J Cell Biol.
200:373–383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maas SLN, Breakefield XO and Weaver AM:
Extracellular vesicles: Unique intercellular delivery vehicles.
Trends Cell Biol. 27:172–188. 2017. View Article : Google Scholar
|
|
13
|
Gallo A, Tandon M, Alevizos I and Illei
GG: The majority of microRNAs detectable in serum and saliva is
concentrated in exosomes. PLoS One. 7:e306792012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ren J, He W, Zheng L and Duan H: From
structures to functions: Insights into exosomes as promising drug
delivery vehicles. Biomater Sci. 4:910–921. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
EL Andaloussi S, Mäger I, Breakefield XO
and Wood MJ: Extracellular vesicles: Biology and emerging
therapeutic opportunities. Nat Rev Drug Discov. 12:347–357. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gilligan KE and Dwyer RM: Engineering
exosomes for cancer therapy. Int J Mol Sci. 18:11222017. View Article : Google Scholar
|
|
17
|
Namee NM and O'Driscoll L: Extracellular
vesicles and anti-cancer drug resistance. Biochim Biophys Acta Rev
Cancer. 1870:123–136. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mori MA, Ludwig RG, Garcia-Martin R,
Brandão BB and Kahn CR: Extracellular miRNAs: From biomarkers to
mediators of physiology and disease. Cell Metab. 30:656–673. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Suchorska WM and Lach MS: The role of
exosomes in tumor progression and metastasis (Review). Oncol Rep.
35:1237–1244. 2016. View Article : Google Scholar
|
|
20
|
Margolis L and Sadovsky Y: The biology of
extracellular vesicles: The known unknowns. PLoS Biol.
17:e30003632019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vella LJ, Hill AF and Cheng L: Focus on
extracellular vesicles: Exosomes and their role in protein
trafficking and biomarker potential in alzheimer's and parkinson's
disease. Int J Mol Sci. 17:1732016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Y, Xi H, Nie X and Yuan W, Zhang P,
Lan N, Lu Y, Liu J and Yuan W: Assessment of miR-212 and other
biomarkers in the diagnosis and treatment of HBV-infection-related
liver diseases. Curr Drug Metab. 20:785–798. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Colombo M, Raposo G and Thery C:
Biogenesis, secretion, and intercellular interactions of exosomes
and other extracellular vesicles. Annu Rev Cell Dev Biol.
30:255–289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pegtel DM and Gould SJ: Exosomes Annu Rev
Biochem. 88:487–514. 2019. View Article : Google Scholar
|
|
25
|
Théry C, Witwer KW, Aikawa E, Alcaraz MJ,
Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F,
Atkin-Smith GK, et al: Minimal information for studies of
extra-cellular vesicles 2018 (MISEV2018): A position statement of
the International Society for Extracellular Vesicles and update of
the MISEV2014 guidelines. J Extracell Vesicles. 7:15357502018.
View Article : Google Scholar
|
|
26
|
Trams EG, Lauter CJ, Salem N Jr and Heine
U: Exfoliation of membrane ectoenzymes in the form of
micro-vesicles. Biochim Biophys Acta. 645:63–70. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Harding C, Heuser J and Stahl P:
Endocytosis and intracellular processing of transferrin and
colloidal gold-transferrin in rat reticulocytes: Demonstration of a
pathway for receptor shedding. Eur J Cell Biol. 35:256–263.
1984.PubMed/NCBI
|
|
28
|
Johnstone RM, Adam M, Hammond JR, Orr L
and Turbide C: Vesicle formation during reticulocyte maturation.
Association of plasma membrane activities with released vesicles
(exosomes). J Biol Chem. 262:9412–9420. 1987.PubMed/NCBI
|
|
29
|
Raposo G, Nijman HW, Stoorvogel W,
Liejendekker R, Harding CV, Melief CJ and Geuze HJ: B lymphocytes
secrete antigen-presenting vesicles. J Exp Med. 183:1161–1172.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zitvogel L, Regnault A, Lozier A, Wolfers
J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G and
Amigorena S: Eradication of established murine tumors using a novel
cell-free vaccine: Dendritic cell-derived exosomes. Nat Med.
4:594–600. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vanaja SK, Russo AJ, Behl B, Banerjee I,
Yankova M, Deshmukh SD and Rathinam VAK: Bacterial outer membrane
vesicles mediate cytosolic localization of LPS and caspase-11
activation. Cell. 165:1106–1119. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mizrak A, Bolukbasi MF, Ozdener GB,
Brenner GJ, Madlener S, Erkan EP, Ströbel T, Breakefield XO and
Saydam O: Genetically engineered microvesicles carrying suicide
mRNA/protein inhibit schwannoma tumor growth. Mol Ther. 21:101–108.
2013. View Article : Google Scholar
|
|
34
|
Maacha S, Bhat AA, Jimenez L, Raza A,
Haris M, Uddin S and Grivel JC: Extracellular vesicles-mediated
intercellular commu-nication: Roles in the tumor microenvironment
and anti-cancer drug resistance. Mol Cancer. 18:552019. View Article : Google Scholar
|
|
35
|
Lee JC, Zhao JT, Gundara J, Serpell J,
Bach LA and Sidhu S: Papillary thyroid cancer-derived exosomes
contain miRNA-146b and miRNA-222. J Surg Res. 196:39–48. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Geraldo MV, Yamashita AS and Kimura ET:
MicroRNA miR-146b-5p regulates signal transduction of TGF-β by
repressing SMAD4 in thyroid cancer. Oncogene. 31:1910–1922. 2012.
View Article : Google Scholar
|
|
37
|
Visone R, Russo L, Pallante P, De Martino
I, Ferraro A, Leone V, Borbone E, Petrocca F, Alder H, Croce CM and
Fusco A: MicroRNAs (miR)-221 and miR-222, both overexpressed in
human thyroid papillary carcinomas, regulate p27Kip1 protein levels
and cell cycle. Endocr Relat Cancer. 14:791–798. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu G, Zhou W, Pan X, Sun Z, Sun Y, Xu H,
Shi P, Li J, Gao L and Tian X: Circular RNA profiling reveals
exosomal circ_0006156 as a novel biomarker in papillary thyroid
cancer. Mol Ther Nucleic Acids. 19:1134–1344. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu G, Zhou W, Lin X, Sun Y, Li J, Xu H,
Shi P, Gao L and Tian X: circRASSF2 Acts as ceRNA and promotes
papillary thyroid carcinoma progression through miR-1178/TLR4
signaling pathway. Mol Ther Nucleic Acids. 19:1153–1163. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Greening DW, Gopal SK, Mathias RA, Liu L,
Sheng J, Zhu HJ and Simpson RJ: Emerging roles of exosomes during
epithelial-mesenchymal transition and cancer progression. Semin
Cell Dev Biol. 40:60–71. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Luo D, Zhan S, Xia W, Huang L, Ge W and
Wang T: Proteomics study of serum exosomes from papillary thyroid
cancer patients. Endocr Relat Cancer. 25:879–891. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Peinado H, Alečković M, Lavotshkin S,
Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M,
Williams C, García-Santos G, Ghajar C, et al: Melanoma exosomes
educate bone marrow progenitor cells toward a pro-metastatic
phenotype through MET. Nat Med. 18:883–891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Melo SA, Luecke LB, Kahlert C, Fernandez
AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari
N, et al: Glypican-1 identifies cancer exosomes and detects early
pancreatic cancer. Nature. 523:177–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Costa-Silva B, Aiello NM, Ocean AJ, Singh
S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, et
al: Pancreatic cancer exosomes initiate pre-metastatic niche
formation in the liver. Nat Cell Biol. 17:816–826. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Henderson YC, Toro-Serra R, Chen Y, Ryu J,
Frederick MJ, Zhou G, Gallick GE, Lai SY and Clayman GL: Src
inhibitors in suppression of papillary thyroid carcinoma growth.
Head Neck. 36:375–384. 2014. View Article : Google Scholar
|
|
46
|
Wang C, Yan G, Zhang Y, Jia X and Bu P:
Long non-coding RNA MEG3 suppresses migration and invasion of
thyroid carcinoma by targeting of Rac1. Neoplasma. 62:541–549.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hardin H, Helein H, Meyer K, Robertson S,
Zhang R, Zhong W and Lloyd R V: Thyroid cancer stem-like cell
exosomes: Regulation of EMT via transfer of lncRNAs. Lab Invest.
98:1133–1142. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yang C, Wei Y, Yu L and Xiao Y:
Identification of altered circular RNA expression in serum exosomes
from patients with papillary thyroid carcinoma by high-throughput
sequencing. Med Sci Moni. 25:2785–2791. 2019. View Article : Google Scholar
|
|
49
|
Ye W, Deng X and Fan Y: Exosomal
miRNA423-5p mediated oncogene activity in papillary thyroid
carcinoma: A potential diagnostic and biological target for cancer
therapy. Neoplasma. 66:516–523. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jiang K, Li G, Chen W, Song L, Wei T, Li
Z, Gong R, Lei J, Shi H and Zhu J: Plasma Exosomal miR-146b-5p and
miR-222-3p are potential biomarkers for lymph node metastasis in
papillary thyroid carcinomas. Onco Targets Ther. 13:1311–1319.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Thery C, Zitvogel L and Amigorena S:
Exosomes: Composition, biogenesis and function. Nat Rev Immunol.
2:569–579. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bravo-Miana RDC, Della Vedova AB, De Paul
AL, Remedi MM, Guantay ML, Gilardoni MB, Pellizas CG and Donadio
AC: Thyroid tumor cells-fibroblasts crosstalk: Role of
extracellular vesicles. Endocr Connect. 9:506–518. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wu F, Li F, Lin X, Xu F, Cui RR, Zhong JY,
Zhu T, Shan SK, Liao XB, Yuan LQ and Mo ZH: Exosomes increased
angiogenesis in papillary thyroid cancer microenvironment. Endocr
Relat Cancer. 26:525–538. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
van Niel G, D'Angelo G and Raposo G:
Shedding light on the cell biology of extracellular vesicles. Nat
Rev Mol Cell Biol. 19:213–228. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wang G, Wang S, Zhang M, Li Y, Liu Q, Sun
N, Zhang X, Liu Y, Zhang J, He L, et al: EV PD-L1 is correlated
with clinical features and contributes to t cell suppression in
pediatric thyroid cancer. J Clin Endocrinol Metab. 105:dgaa3092020.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Cheng L, Sharples RA, Scicluna BJ and Hill
AF: Exosomes provide a protective and enriched source of miRNA for
biomarker profiling compared to intracellular and cell-free blood.
J Extracell Vesicles. 3:2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Qiao F, Pan P, Yan J, Sun J, Zong Y, Wu Z,
Lu X, Chen N, Mi R, Ma Y and Ji Y: Role of tumor-derived
extracellular vesicles in cancer progression and their clinical
applications (Review). Int J Oncol. 54:1525–1533. 2019.PubMed/NCBI
|
|
58
|
Pan Q, Zhao J, Li M, Liu X, Xu Y, Li W, Wu
S and Su Z: Exosomal miRNAs are potential diagnostic biomarkers
between malignant and benign thyroid nodules based on
next-generation sequencing. Carcinogenesis. 41:18–24. 2020.
|
|
59
|
Samsonov R, Burdakov V, Shtam T,
Radzhabovsmall Z, Vasilyev D, Tsyrlina E, Titov S, Ivanov M,
Berstein L, et al: Plasma exosomal miR-21 and miR-181a
differentiates follicular from papillary thyroid cancer. Tumour
Biol. 37:12011–12021. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang Z, Lv J, Zou X, Huang Z, Zhang H, Liu
Q, Jiang L, Zhou X and Zhu W: A three plasma microRNA signature for
papillary thyroid carcinoma diagnosis in Chinese patients. Gene.
693:37–45. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Dai D, Tan Y, Guo L, Tang A and Zhao Y:
Identification of exosomal miRNA biomarkers for diagnosis of
papillary thyroid cancer by small RNA sequencing. Eur J Endocrinol.
182:111–121. 2020. View Article : Google Scholar
|
|
62
|
Rappa G, Puglisi C, Santos MF, Forte S,
Memeo L and Lorico A: Extracellular vesicles from thyroid
carcinoma: The new frontier of liquid biopsy. Int J Mol Sci.
20:11142019. View Article : Google Scholar
|
|
63
|
Liang M, Yu S, Tang S, Bai L, Cheng J, Gu
Y, Li S, Zheng X, Duan L, Wang L, et al: A Panel of Plasma exosomal
miRNAs as potential biomarkers for differential diagnosis of
thyroid nodules. Front Genet. 11:4492020. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Huang TY, Wang CY, Chen KY and Huang LT:
Urinary exosomal thyroglobulin in thyroid cancer patients with
post-ablative therapy: A new biomarker in thyroid cancer. Front
Endocrinol (Lausanne). 11:3822020. View Article : Google Scholar
|
|
65
|
Caruso Bavisotto C, Cipolla C, Graceffa G,
Barone R, Bucchieri F, Bulone D, Cabibi D, Campanella C, Marino
Gammazza A, Pitruzzella A, et al: Immunomorphological pattern of
molecular chaperones in normal and pathological thyroid tissues and
circulating exosomes: Potential use in Clinics. Int J Mol Sci.
20:44962019. View Article : Google Scholar
|
|
66
|
Zhuang X, Xiang X, Grizzle W, Sun D, Zhang
S, Axtell RC, Ju S, Mu J, Zhang L, Steinman L, et al: Treatment of
brain inflammatory diseases by delivering exosome encapsulated
anti-inflammatory drugs from the nasal region to the brain. Mol
Ther. 19:1769–1779. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Yang T, Martin P, Fogarty B, Brown A,
Schurman K, Phipps R, Yin VP, Lockman P and Bai S: Exosome
delivered anticancer drugs across the blood-brain barrier for brain
cancer therapy in Danio rerio. Pharm Res. 32:2003–2014. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Smyth T, Kullberg M, Malik N, Smith-Jones
P, Graner MW and Anchordoquy TJ: Biodistribution and delivery
efficiency of unmodified tumor-derived exosomes. J Control Release.
199:145–155. 2015. View Article : Google Scholar
|
|
69
|
Kim SM, Yang Y, Oh SJ, Hong Y, Seo M and
Jang M: Cancer-derived exosomes as a delivery platform of
CRISPR/Cas9 confer cancer cell tropism-dependent targeting. J
Control Release. 266:8–16. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Rana S, Yue S, Stadel D and Zöller M:
Toward tailored exosomes: The exosomal tetraspanin web contributes
to target cell selection. Int J Biochem Cell Biol. 44:1574–1584.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhang H, Wang Y, Bai M, Wang J, Zhu K, Liu
R, Ge S, Li J, Ning T, Deng T, et al: Exosomes serve as
nanoparticles to suppress tumor growth and angiogenesis in gastric
cancer by delivering hepatocyte growth factor siRNA. Cancer Sci.
109:629–641. 2018. View Article : Google Scholar
|
|
72
|
Gangadaran P, Li XJ, Kalimuthu SK, Min OJ,
Hong CM, Rajendran RL, Lee HW, Zhu L, Baek SH and Jeong SY: New
optical imaging reporter-labeled anaplastic thyroid cancer-derived
extracellular vesicles as a platform for in vivo tumor targeting in
a mouse model. Sci Rep. 8:135092018. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhu L, Kalimuthu S, Oh JM, Gangadaran P,
Baek SH, Jeong SY, Lee SW, Lee J and Ahn BC: Enhancement of
antitumor potency of extracellular vesicles derived from natural
killer cells by IL-15 priming. Biomaterials. 190-191:38–50. 2019.
View Article : Google Scholar
|
|
74
|
Lugini L, Cecchetti S, Huber V, Luciani F,
Macchia G, Spadaro F, Paris L, Abalsamo L, Colone M, Molinari A, et
al: Immune surveillance properties of human NK cell-derived
exosomes. J Immunol. 189:2833–2842. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Kim OY, Choi SJ, Jang SC, Park KS, Kim SR,
Choi JP, Lim JH, Lee SW, Park J, Di Vizio D, et al: Bacterial
protoplast-derived nanovesicles as vaccine delivery system against
bacterial infection. Nano Lett. 15:266–274. 2015. View Article : Google Scholar
|
|
76
|
Yang Z, Xie J, Zhu J, Kang C, Chiang C,
Wang X, Wang X, Kuang T, Chen F, Chen Z, et al: Functional
exosome-mimic for delivery of siRNA to cancer: In vitro and in vivo
evaluation. J Control Release. 243:160–171. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhu L, Gangadaran P, Kalimuthu S, Oh JM,
Baek SH, Jeong SY, Lee SW, Lee J and Ahn BC: Novel alternatives to
extracellular vesicle-based immunotherapy-exosome mimetics derived
from natural killer cells. Artif Cells Nanomed Biotechnol.
46(sup3): S166–S179. 2018. View Article : Google Scholar
|
